Australia markets closed

NeuroScientific Biopharmaceuticals Limited (NSB.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.0530+0.0020 (+3.92%)
At close: 01:17PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 3-28.38%
S&P500 52-week change 322.38%
52-week high 30.1350
52-week low 30.0340
50-day moving average 30.0487
200-day moving average 30.0639

Share statistics

Avg vol (3-month) 3204.08k
Avg vol (10-day) 397.22k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8100.47M
% held by insiders 134.84%
% held by institutions 14.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 20.06%
Operating margin (ttm)16.69%

Management effectiveness

Return on assets (ttm)10.22%
Return on equity (ttm)23.29%

Income statement

Revenue (ttm)3.79M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 703.68k
Net income avi to common (ttm)761.17k
Diluted EPS (ttm)-0.0440
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.34M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)29.55
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)12.3k
Levered free cash flow (ttm)-405.58k